Exclusion of alternative diagnoses: A component of the 2023 MOGAD criteria that belongs at the forefront, not in the background
A recent study evaluating the diagnostic performance of the 2023 MOGAD criteria found that it had relatively low specificity. However, this study did not apply the component of these criteria that requires exclusion of alternative diagnoses (item C) when evaluating its performance, raising questions...
Gespeichert in:
Veröffentlicht in: | Multiple sclerosis and related disorders 2024-05, Vol.85, p.105544, Article 105544 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | 105544 |
container_title | Multiple sclerosis and related disorders |
container_volume | 85 |
creator | Budhram, Adrian |
description | A recent study evaluating the diagnostic performance of the 2023 MOGAD criteria found that it had relatively low specificity. However, this study did not apply the component of these criteria that requires exclusion of alternative diagnoses (item C) when evaluating its performance, raising questions surrounding the relevance of the study's findings to the use of these criteria in routine practice. This correspondence acknowledges the challenge of clinically applying this component of diagnostic criteria, discusses what exclusion of alterative diagnoses actually entails conceptually, and emphasizes the importance of its inclusion in future studies aimed at evaluating the performance of proposed criteria. |
doi_str_mv | 10.1016/j.msard.2024.105544 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2956163227</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2211034824001238</els_id><sourcerecordid>2956163227</sourcerecordid><originalsourceid>FETCH-LOGICAL-c309t-be3a9bd30212a68ee574f4c1a24a0a28b79e5575d16a27809da6646e4a495af13</originalsourceid><addsrcrecordid>eNp9kM1u1DAUhS0EolXpEyAhL1kwg_-TILEYlbYgFXUDa-vGuRk8JPZgOxWsePV6OqVLvPHV0Xd8rg8hrzlbc8bN-916zpCGtWBCVUVrpZ6RUyE4XzGpzfOnWbUn5DznHavHaK4Mf0lOZKtMwzp-Sv5e_nbTkn0MNI4UpoIpQPF3SAcP2xAz5g90Q12c9zFgKAeq_EBacyX9enu9-URd8tXloepQaI9TDNtM63jgxphwTDGUdzTEQn14UHtwP7cpLmF4RV6MMGU8f7zPyPery28Xn1c3t9dfLjY3KydZV1Y9Suj6QTLBBZgWUTdqVI6DUMBAtH3TodaNHrgB0bSsG8AYZVCB6jSMXJ6Rt8d39yn-WjAXO_vscJogYFyyFZ023EghmorKI-pSzLmub_fJz5D-WM7soXy7sw_l20P59lh-db15DFj6GYcnz7-qK_DxCGD95p3HZLPzGBwOPqErdoj-vwH3AHaVpg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2956163227</pqid></control><display><type>article</type><title>Exclusion of alternative diagnoses: A component of the 2023 MOGAD criteria that belongs at the forefront, not in the background</title><source>Alma/SFX Local Collection</source><creator>Budhram, Adrian</creator><creatorcontrib>Budhram, Adrian</creatorcontrib><description>A recent study evaluating the diagnostic performance of the 2023 MOGAD criteria found that it had relatively low specificity. However, this study did not apply the component of these criteria that requires exclusion of alternative diagnoses (item C) when evaluating its performance, raising questions surrounding the relevance of the study's findings to the use of these criteria in routine practice. This correspondence acknowledges the challenge of clinically applying this component of diagnostic criteria, discusses what exclusion of alterative diagnoses actually entails conceptually, and emphasizes the importance of its inclusion in future studies aimed at evaluating the performance of proposed criteria.</description><identifier>ISSN: 2211-0348</identifier><identifier>ISSN: 2211-0356</identifier><identifier>EISSN: 2211-0356</identifier><identifier>DOI: 10.1016/j.msard.2024.105544</identifier><identifier>PMID: 38467091</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Autoantibody ; Diagnostic criteria ; MOG ; Myelin oligodendrocyte glycoprotein ; Neural antibody</subject><ispartof>Multiple sclerosis and related disorders, 2024-05, Vol.85, p.105544, Article 105544</ispartof><rights>2024 Elsevier B.V.</rights><rights>Copyright © 2024 Elsevier B.V. All rights reserved.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c309t-be3a9bd30212a68ee574f4c1a24a0a28b79e5575d16a27809da6646e4a495af13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38467091$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Budhram, Adrian</creatorcontrib><title>Exclusion of alternative diagnoses: A component of the 2023 MOGAD criteria that belongs at the forefront, not in the background</title><title>Multiple sclerosis and related disorders</title><addtitle>Mult Scler Relat Disord</addtitle><description>A recent study evaluating the diagnostic performance of the 2023 MOGAD criteria found that it had relatively low specificity. However, this study did not apply the component of these criteria that requires exclusion of alternative diagnoses (item C) when evaluating its performance, raising questions surrounding the relevance of the study's findings to the use of these criteria in routine practice. This correspondence acknowledges the challenge of clinically applying this component of diagnostic criteria, discusses what exclusion of alterative diagnoses actually entails conceptually, and emphasizes the importance of its inclusion in future studies aimed at evaluating the performance of proposed criteria.</description><subject>Autoantibody</subject><subject>Diagnostic criteria</subject><subject>MOG</subject><subject>Myelin oligodendrocyte glycoprotein</subject><subject>Neural antibody</subject><issn>2211-0348</issn><issn>2211-0356</issn><issn>2211-0356</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kM1u1DAUhS0EolXpEyAhL1kwg_-TILEYlbYgFXUDa-vGuRk8JPZgOxWsePV6OqVLvPHV0Xd8rg8hrzlbc8bN-916zpCGtWBCVUVrpZ6RUyE4XzGpzfOnWbUn5DznHavHaK4Mf0lOZKtMwzp-Sv5e_nbTkn0MNI4UpoIpQPF3SAcP2xAz5g90Q12c9zFgKAeq_EBacyX9enu9-URd8tXloepQaI9TDNtM63jgxphwTDGUdzTEQn14UHtwP7cpLmF4RV6MMGU8f7zPyPery28Xn1c3t9dfLjY3KydZV1Y9Suj6QTLBBZgWUTdqVI6DUMBAtH3TodaNHrgB0bSsG8AYZVCB6jSMXJ6Rt8d39yn-WjAXO_vscJogYFyyFZ023EghmorKI-pSzLmub_fJz5D-WM7soXy7sw_l20P59lh-db15DFj6GYcnz7-qK_DxCGD95p3HZLPzGBwOPqErdoj-vwH3AHaVpg</recordid><startdate>20240501</startdate><enddate>20240501</enddate><creator>Budhram, Adrian</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240501</creationdate><title>Exclusion of alternative diagnoses: A component of the 2023 MOGAD criteria that belongs at the forefront, not in the background</title><author>Budhram, Adrian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c309t-be3a9bd30212a68ee574f4c1a24a0a28b79e5575d16a27809da6646e4a495af13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Autoantibody</topic><topic>Diagnostic criteria</topic><topic>MOG</topic><topic>Myelin oligodendrocyte glycoprotein</topic><topic>Neural antibody</topic><toplevel>online_resources</toplevel><creatorcontrib>Budhram, Adrian</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Multiple sclerosis and related disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Budhram, Adrian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exclusion of alternative diagnoses: A component of the 2023 MOGAD criteria that belongs at the forefront, not in the background</atitle><jtitle>Multiple sclerosis and related disorders</jtitle><addtitle>Mult Scler Relat Disord</addtitle><date>2024-05-01</date><risdate>2024</risdate><volume>85</volume><spage>105544</spage><pages>105544-</pages><artnum>105544</artnum><issn>2211-0348</issn><issn>2211-0356</issn><eissn>2211-0356</eissn><abstract>A recent study evaluating the diagnostic performance of the 2023 MOGAD criteria found that it had relatively low specificity. However, this study did not apply the component of these criteria that requires exclusion of alternative diagnoses (item C) when evaluating its performance, raising questions surrounding the relevance of the study's findings to the use of these criteria in routine practice. This correspondence acknowledges the challenge of clinically applying this component of diagnostic criteria, discusses what exclusion of alterative diagnoses actually entails conceptually, and emphasizes the importance of its inclusion in future studies aimed at evaluating the performance of proposed criteria.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>38467091</pmid><doi>10.1016/j.msard.2024.105544</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2211-0348 |
ispartof | Multiple sclerosis and related disorders, 2024-05, Vol.85, p.105544, Article 105544 |
issn | 2211-0348 2211-0356 2211-0356 |
language | eng |
recordid | cdi_proquest_miscellaneous_2956163227 |
source | Alma/SFX Local Collection |
subjects | Autoantibody Diagnostic criteria MOG Myelin oligodendrocyte glycoprotein Neural antibody |
title | Exclusion of alternative diagnoses: A component of the 2023 MOGAD criteria that belongs at the forefront, not in the background |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T16%3A44%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exclusion%20of%20alternative%20diagnoses:%20A%20component%20of%20the%202023%20MOGAD%20criteria%20that%20belongs%20at%20the%20forefront,%20not%20in%20the%20background&rft.jtitle=Multiple%20sclerosis%20and%20related%20disorders&rft.au=Budhram,%20Adrian&rft.date=2024-05-01&rft.volume=85&rft.spage=105544&rft.pages=105544-&rft.artnum=105544&rft.issn=2211-0348&rft.eissn=2211-0356&rft_id=info:doi/10.1016/j.msard.2024.105544&rft_dat=%3Cproquest_cross%3E2956163227%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2956163227&rft_id=info:pmid/38467091&rft_els_id=S2211034824001238&rfr_iscdi=true |